In a study using human muscle satellite cells, it was found that rosiglitazone promoted adipogenic differentiation and activated PPARγ expression, which gives a hint of the presence of adipocytes in the skeletal muscle, as can be shown for diabetes and obesity during the course of aging [35]. The gene discussed is PPARG; the disease is obesity due to melanocortin 4 receptor deficiency.